Roche Holding AG
If you can't build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies — […]
Read More
Roche enters obesity market with Carmot takeover but medications could not be accessible until finally 2030
BRAZIL – 2021/11/26: In this photograph illustration a F. HoffmannLa Roche AG logo is found on a screen and a hand keeping a capsule. (Picture Illustration by Rafael Henrique/SOPA Visuals/LightRocket by way of Getty Pictures) Sopa Photos | Lightrocket | Getty Photos Swiss prescribed drugs giant Roche is established to purchase anti being overweight drug […]
Read More
BofA reveals the worldwide stocks that tend to outperform when the U.S. dollar rises
The U.S. dollar has been on a tear following the Federal Reserve’s apparent motivation to larger-for-for a longer time fascination rates. Whilst economies and stock markets around the world are probably to arrive underneath tension in this kind of a situation, a raft of European stocks could in fact achieve from the climbing U.S. greenback, […]
Read More
Europe stocks close 1.4% lower as investors digest U.S. rating downgrade
Europe stocks close lower The Stoxx 600 index fell for a second consecutive session Wednesday to a more than two-week low. Germany’s DAX and the U.K.’s FTSE 100 both declined by around 1.36% as France’s CAC 40 dropped 1.26%. Stock Chart IconStock chart icon Stoxx 600 index. Economists doubt U.S. debt downgrade will have lasting […]
Read More
‘Good price, lower threat, large quality’: BofA names leading Europe shares to beat a recession
Financial institution of America has named several European “leading shares” it claims are of “excellent price, very low hazard” and “superior excellent.” All of them turned up on “economic downturn screens” for July, in a market place BofA explained as a being in a recession model cycle. A model cycle refers to the marriage among […]
Read More
Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buyback
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company […]
Read More
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
A man wearing a mask walks past a Nvidia logo in Taipei, Taiwan. Sopa Images | Lightrocket | Getty Images Chipmaker Nvidia will invest $50 million in Recursion Pharmaceuticals to speed up the development of the biotech firm’s artificial intelligence models for drug discovery, the companies said Wednesday. Recursion’s stock soared 80% following the announcement. […]
Read More
Regeneron shares fall right after Fda rejects large-dose eye condition remedy
Perspective of Company and Investigate and Growth Headquarters of Regeneron Prescription drugs on Previous Observed Mill River Highway in Tarrytown, New York. Lev Radin | LightRocket | Getty Images Shares of Regeneron fell nearly 9% on Tuesday immediately after the U.S. Meals and Drug Administration declined to approve a better-dose variation of the firm’s blockbuster […]
Read More
Citi names its major biotech and pharma stock picks, offering one approximately 90% upside
The health care sector outperformed in Europe, India and China previous thirty day period, according to Citi, which named its major picks around the globe. Europe’s pharma sector appears to be significantly robust, the financial institution mentioned in a May 4 take note, with European big caps observing consensus earnings updates in April and favourable […]
Read More
Roche flags 2023 earnings decline on slump in Covid merchandise
A perspective of the Roche towers, built by architects Herzog and de Meuron, the headquarters of the Swiss pharma large Roche, in Basel. Gabriel Monnet | Afp | Getty Photos Roche warned of a decline in 2023 earnings, as revenue growth from new medicines like haemophilia treatment method Hemlibra and several sclerosis drug Ocrevus would […]
Read More